Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fewer Acquisitions And Alliances In 2023, But Valuations Increased

Feb 05 2024

• By Joseph Haas

Scrip Perspectives 2023/2024: 2023 Deals Overview — In both M&A and alliances, 2023 saw lower deal volume but higher deal valuations • Source: Shutterstock

Related Content

2022 Deal-Making Snapshot: One Big Deal Didn’t Change The Downward Trends

Apr 21 2023

Roche And Recursion’s AI Drug Discovery Pact To Focus On Neuroscience

Dec 08 2021

Related Companies

Pfizer Inc.

Seagen Inc.

Amgen, Inc.

Horizon Therapeutics plc

ImmunoGen, Inc.

Merck & Co., Inc.

Daiichi Sankyo Co., Ltd.

Roche Holding AG

Recursion Pharmaceuticals, Inc.

Bristol Myers Squibb Company

SystImmune Inc.

Nurix Therapeutics, Inc.

Additional Topics

Deals M & A Business Strategies Commercial Scrip Perspectives BioPharmaceutical

More from Scrip Perspectives

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window